Analysis of mutations of MDR3 exons 9 and 23 in infants with parenteral nutrition-associated cholestasis

Yang,Xiu‑Fang; Liu,Guo‑Sheng; Li,Min‑Xu

doi:10.3892/etm.2015.2800

Analysis of mutations of MDR3 exons 9 and 23 in infants with parenteral nutrition-associated cholestasis

Authors:
- Xiu‑Fang Yang
- Guo‑Sheng Liu
- Min‑Xu Li
View Affiliations

Affiliations: Department of Neonatology, Zhongshan People's Hospital Affiliated to Sun Yat‑sen University, Zhongshan, Guangdong 528403, P.R. China, Department of Neonatology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China, Dongguan Maternal and Child Health Center, Dongguan, Guangdong 523000, P.R. China
Published online on: October 14, 2015 https://doi.org/10.3892/etm.2015.2800
Pages: 2361-2365

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate mutations of multidrug resistance 3 (MDR3) exons 9 and 23 in infants with parenteral nutrition‑associated cholestasis (PNAC). A total of 41 infants with PNAC were enrolled in the study. Genomic DNA was extracted from the peripheral venous blood leukocytes of each patient and MDR3 exons 9 and 23 were amplified by polymerase chain reaction. One patient was identified who carried a frameshift mutation in MDR3 exon 23 (C.2793) that was caused by the insertion of a single adenine residue, while mutations were not found in MDR3 exon 23 in the other 40 patients. The clinical features of the patient with the MDR3 exon 23 frameshift mutation included high serum γ-glutamyl transferase levels, the absence of biliary dilatation and deformity in magnetic resonance cholangiopancreatography, and abnormal electrical capacitance tomography imaging of the liver. No mutations in MDR3 exon 9 were identified in any of the patients. All 41 PNAC patients recovered following oral ursodeoxycholic acid treatment. The C.2793 frameshift mutation in MDR3 exon 23 is potentially associated with the development of PNAC in infants.

View Figures

View References

1	Dudrick SJ, Wilmore DW, Vars HM and Rhoads JE: Long-term total parenteral nutrition with growth development and positive nitrogen balance. Surgery. 64:134–142. 1968.PubMed/NCBI
2	Peden VH, Witzleben CL and Skelton MA: Total parenteral nutrition. J Pediatr. 78:180–181. 1971. View Article : Google Scholar : PubMed/NCBI
3	Suchy FJ, Sokol RJ and Balistreri WF: Approach to the infant with cholestasis. Liver Disease in Children (2nd). (Philadelphia). Lippincott Williams and Wilkins. 187–194. 2001.
4	Benchimol EI, Walsh CM and Ling SC: Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks. Can Fam Physician. 55:1184–1192. 2009.PubMed/NCBI
5	Baserga MC and Sola A: Intrauterine growth restriction impacts tolerance to total parenteral nutrition in extremely low birth weight infants. J Perinatol. 24:476–481. 2004. View Article : Google Scholar : PubMed/NCBI
6	Kaufman SS, Gondolesi GE and Fishbein TM: Parenteral nutrition associated liver disease. Semin Neonatol. 8:375–381. 2003. View Article : Google Scholar : PubMed/NCBI
7	Hu HP, Zhou HB and Zhou DX: Molecular mechanism of bile formation and cholestatic diseases. Zhonghua Gan Zang Bing Za Zhi. 16:571–573. 2008.(In Chinese). PubMed/NCBI
8	Oude Elferink RP and Paulusma CC: Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch. 453:601–610. 2007. View Article : Google Scholar : PubMed/NCBI
9	Cholestatic Liver Disease Diagnosis and Treatment Expert Committee. Experts consensus on diagnosis and therapy of cholestasis. Chinese Journal of Experimental and Clinical Infectious Diseases (Electronic edition). 3:474–487. 2009.(In Chinese).
10	Barnett R and Larson G: A phenol-chloroform protocol for extracting DNA from ancient samples. Methods Mol Biol. 840:13–19. 2012. View Article : Google Scholar : PubMed/NCBI
11	Cardoso Pinto G, Abily-Donval L, Chadie A, et al: Epidemiological study of very preterm infants at Rouen University Hospital: changes in mortality, morbidity, and care over 11 years. Arch Pediatr. 20:156–163. 2013.(In French). PubMed/NCBI
12	Klein CJ, Revenis M, Kusenda C and Scavo L: Parenteral nutrition associated conjugated hyperbilirubinemia in hospitalized infants. J Am Diet Assoc. 110:1684–1695. 2010. View Article : Google Scholar : PubMed/NCBI
13	Robinson DT and Ehrenkranz RA: Parenteral nutrition-associated cholestasis in small for gestational age infants. J Pediatr. 152:59–62. 2008. View Article : Google Scholar : PubMed/NCBI
14	Rafeey M, Golzar A and Javadzadeh A: Cholestatic syndromes of infancy. Pak J Biol Sci. 11:1764–1767. 2008. View Article : Google Scholar : PubMed/NCBI
15	Pasmant E, Goussard P, Baranes L, et al: First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis. Eur J Hum Genet. 20:277–282. 2012. View Article : Google Scholar : PubMed/NCBI
16	Poupon R, Barbu V, Chamouard P, Wendum D, Rosmorduc O and Housset C: Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3. Liver Int. 30:327–331. 2010. View Article : Google Scholar : PubMed/NCBI
17	Colombo C, Vajro P, Degiorgio D, et al: Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr. 52:73–83. 2011. View Article : Google Scholar : PubMed/NCBI
18	Degiorgio D, Colombo C, Seia M, et al: Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3). Eur J Hum Genet. 15:1230–1238. 2007. View Article : Google Scholar : PubMed/NCBI
19	van der Woerd WL, van Mil SW, Stapelbroek JM, Klomp LW, van de Graaf SF and Houwen RH: Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Pract Res Clin Gastroenterol. 24:541–553. 2010. View Article : Google Scholar : PubMed/NCBI
20	Wasmuth HE, Glantz A, Keppeler H, et al: Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut. 56:265–270. 2007. View Article : Google Scholar : PubMed/NCBI
21	Schneider G, Paus TC, Kullak-Ublick GA, et al: Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Heptology. 45:150–158. 2007. View Article : Google Scholar
22	Harikar W, Kansal S, Oude Elferink RP and Angus P: Intrahepatic cholestasis of pregnancy: when should you look further? World J Gastroenterol. 15:1126–1129. 2009. View Article : Google Scholar : PubMed/NCBI
23	Ziol M, Barbu V, Rosmorduc O, et al: BCB 4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults. Gastroenterology. 135:31–141. 2008. View Article : Google Scholar
24	Denk GU, Bikker H, Lekanne Dit, Deprez RH, et al: ABCB4 deficiency: a family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene. Hepatol Res. 40:937–941. 2010. View Article : Google Scholar : PubMed/NCBI
25	Kullak-Ublick GA, Stieger B and Meier PJ: Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterorlogy. 126:322–342. 2004. View Article : Google Scholar
26	Groen A, Romero MR, Kunne C, et al: Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity. Gastroenterology. 141:1927–1937. 2011. View Article : Google Scholar : PubMed/NCBI
27	Karpen SJ: Transcriptional regulation of hepatobiliary transporters. Molecular Pathogenesis of Cholestasis. Trauner M and Jansen PLM: (Georgetown). Landes Bioscience. 124–140. 2003.
28	Elferink Oude RP, Paulusma CC and Groen AK: Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology. 130:908–925. 2006. View Article : Google Scholar : PubMed/NCBI
29	Lincke CR, Smit JJ, van der Velde-Koerts T and Borst P: Structure of the human MDR3 gene and physical mapping of the human MDR locus. J Biol Chem. 266:5303–5310. 1991.PubMed/NCBI
30	Gotthardt D, Runz H, Keitel V, et al: Amutation in the canalicular phospholipid transporter gene, ABCB 4, is associated with cholestasis, ductopenia and cirrhosis in adults. Hepatology. 48:1157–1166. 2008. View Article : Google Scholar : PubMed/NCBI
31	Wendum D, Barbu V, Rosomorduc O, Arrivé L, Fléjou JF and Poupon R: Aspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations. Virchows Arch. 460:291–298. 2012. View Article : Google Scholar : PubMed/NCBI
32	Paulusma CC, Groen A, Kunne C, et al: Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and inpairs bile salt transport. Hepatology. 44:195–204. 2006. View Article : Google Scholar : PubMed/NCBI